In July, Telehealth Utilization Decreased Nationally and in Every US Census Region
Both Acute Respiratory Diseases and Infections and Encounter for Examination Fell Out of the National Top Five Telehealth Diagnostic Categories...
COVID-19
Avant Brands Announces Results for Q3 2024
Record Gross and Net Revenue: Generated $9.6 million Gross Revenue and $8.5 million Net Revenue in Q3 2024, establishing new...
VGXI Selects Cryoport for Biostorage, Bioservices and Supply Chain Solutions to Advance Next-Generation Therapies
Partnership Will Enhance Support for Biopharmaceutical Companies in Developing Cell and Gene Therapies and mRNA-Based Treatments NASHVILLE, Tenn. and CONROE,...
Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal Conference
Leading veterinary experts to present educational programs featuring Zomedica product applications at the Fetch dvm360 Veterinary Conference ANN ARBOR, MI...
NanoViricides President Dr. Diwan Interviwed in PODD Podcast; He Explains the Revolutionary Clinical Stage Broad-Spectrum Antiviral NV-387, and the Potential of the Platform to Revolutionize Fields Beyond Virology
SHELTON, CT / ACCESSWIRE / October 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader...
SeaStar Medical to Showcase New Mechanistic Data Highlighting the Immunomodulatory Effect of the Selective Cytopheretic Device in Acute Kidney Injury at ASN Kidney Week
DENVER, Oct. 15, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary...
Hemostemix’s Private Placement
Calgary, Alberta--(Newsfile Corp. - October 11, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) is pleased to...
The Galien Foundation Hosts 2024 Galien Week of Innovation to Celebrate the Latest Research and Clinical Pathways Toward Diagnoses, Treatments, and Cures
Week Begins with In-Depth Discussions on Life Science Trends and Celebrates Innovative Products that Have Made a Significant Impact on...
AHRQ Awards MEPS-HC to Westat
Westat is honored to continue its partnership with AHRQ to conduct MEPS-HC, which is integral to AHRQ's mission to produce...
Vitestro Welcomes Dave Hickey to Board of Directors as an Independent Board Member
UTRECHT, The Netherlands, Oct. 10, 2024 /PRNewswire/ -- Vitestro, the innovator behind the world's first autonomous blood drawing device, is...
Workflow Management System Market Size Worth $60.02 Billion, Globally, by 2031 – Exclusive Report by The Insight Partners
The workflow management system market size is projected to reach US$ 60.02 billion by 2031 from US$ 10.23 billion in...
Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis
News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA...
Palisade Bio Cleared by Health Canada to Commence Phase 1 Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis (UC)
– Company has received a No Objection Letter from Health Canada in response to submission of its Phase 1 Clinical...
The Infrared Thermometers Market is projected to grow by USD 1.05 Billion (2024-2028), driven by rising contagious and chronic diseases, with AI driving market transformation – Technavio
NEW YORK, Oct. 9, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The Global Infrared Thermometers Market...
Global Health Exhibition to Unveil the World’s Largest Virtual Hospital in Riyadh
Exclusive exhibit will enable attendees to experience simulated patient scenarios and determine treatment and therapy actionsTechnology behind the virtual hospital...
Entourage Health Provides Company Update
TORONTO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a...
Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trials
Data from three separate clinical trials documents the strong ability of the AI-Immunology™ platform to select clinically relevant vaccine targets...
Windtree Announces Publication of Positive Istaroxime Phase 2b Study Trial Design
The Company recently announced the positive topline results from the Phase 2b study with istaroxime in acute heart failure patients...
FDA Grants Orphan Drug Designation to Can-Fite’s Namodenoson for Pancreatic Cancer
RAMAT GAN, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company...
Adagene Announces Upcoming Poster Presentations on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
SAN DIEGO and SUZHOU, China, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the...